How will the HMPV virus in China affect stocks and what stocks specifically will rise

The HMPV virus outbreak in China is likely to have a significant impact on the healthcare sector, leading to increased demand for healthcare services and products. This, in turn, could drive the performance of certain stocks in the market. Here are some potential stock candidates that may see a rise:

|code|stock code|stock name|Last Price|Last Change|GICS Sector|market_code|
|---|---|---|---|---|---|---|
|CTCX|CTCX.O|Carmell|0.6921|147.975636|Health Care|186|
|TXMD|TXMD.O|Therapeuticsmd|1.57|82.55814000000001|Health Care|185|
|QSI|QSI.O|Quantum-Si|4.26|57.777778000000005|Health Care|185|
|PASG|PASG.O|Passage Bio|0.83|46.358667|Health Care|185|
|INKT|INKT.O|MiNK Therapeutics|1.01|44.927536|Health Care|186|
|KLTO|KLTO.O|Klotho Neurosciences|0.6995|44.226803999999994|Health Care|185|
|REVB|REVB.O|Revelation|0.657|42.516269|Health Care|186|
|CRIS|CRIS.O|Curis|4.24|38.562092|Health Care|186|
|NRXP|NRXP.O|NRX Pharmaceuticals|2.99|35.909091|Health Care|186|
|OBIO|OBIO.O|Orchestra BioMed|5.38|34.5|Health Care|185|

The stocks listed above are likely to be influenced by the HMPV virus outbreak in China due to their focus on healthcare-related products and services. However, it's important to note that the actual performance of these stocks will depend on various factors, including the severity and duration of the outbreak, the effectiveness of the Chinese government's response, and broader market conditions. Investors should conduct thorough due diligence before making investment decisions based on such events.